Cesca Therapeutics Gets $15M Cash Infusion From Chinese Research Firm
In other marketplace news, Tobira Therapeutics targets treatments for non-alcoholic steatohepatitis.
The Sacramento Business Journal:
Chinese Research Firm Pours Badly Needed Cash Into Local Biotech Firm
A Chinese stem-cell research company invested $15 million into regenerative medicine company Cesca Therapeutics Inc., the company reported Wednesday. (Anderson, 2/4)
The San Francisco Business Journal:
After Early Drug Breakthroughs, Tobira CEO Makes A Dash For NASH
Laurent Fischer helped push groundbreaking HIV-fighting drugs to market for AIDS patients. So why not tackle another disease where a treatment could be equally lifechanging? (Leuty, 2/4)